Propionibacterium acnes is a bacterium that lives naturally on human skin, primarily inside hair follicles and oil glands. It is one of the most abundant microbes on your body, and in most people it causes no problems at all. But when conditions shift, particularly when oil production increases and pores become blocked, this same bacterium can trigger the inflammation behind acne breakouts. In 2016, scientists reclassified it under a new name, Cutibacterium acnes, to better reflect its skin-dwelling nature, though the older name remains widely used.
Basic Biology of the Bacterium
This microbe is gram-positive, meaning it has a thick cell wall, and it thrives in low-oxygen environments. That makes the deep, oxygen-poor interior of clogged pores an ideal home. It feeds primarily on triglycerides, the oily fats found in sebum (the natural oil your skin produces). Using enzymes called lipases, it breaks these triglycerides down into free fatty acids it can use for energy.
The bacterium grows slowly compared to many other microbes, which is one reason infections it causes outside of acne can be difficult to detect. Cultures sometimes need to be incubated for up to two weeks before it shows up in lab results.
How It Contributes to Acne
Having this bacterium on your skin is completely normal. The problem begins when a pore gets clogged with excess sebum and dead skin cells, creating an enclosed, oxygen-depleted pocket where the bacteria can multiply rapidly. As the bacterial population grows, it breaks down more and more triglycerides in the trapped sebum, releasing free fatty acids, particularly oleic acid. These fatty acids irritate the pore lining, cause skin cells to overgrow and harden (a process called hyperkeratinization), and weaken the skin’s local barrier function.
The immune system then steps in. Your skin cells detect the bacterium through receptors on their surface that recognize it as a potential threat. This triggers a cascade of inflammation: immune cells flood the area and release signaling molecules that cause redness, swelling, and pain. That’s the progression from a simple clogged pore (a whitehead or blackhead) to an inflamed, angry pimple.
Not All Strains Are Equal
One of the more important discoveries in recent acne research is that different strains of this bacterium behave very differently. Scientists classify strains into phylotypes, and certain types are far more common on acne-prone skin while others dominate on healthy, clear skin. Specifically, strains belonging to phylotype IA1 and IA2 are found in higher proportions in people with acne, while strains from phylotypes IB and II are more abundant on healthy skin.
This means acne isn’t simply a matter of having too much of this bacterium. It’s more about which strains dominate and whether the overall microbial community on your skin has lost its diversity. People with clear skin tend to carry a broader mix of strain types, while acne-prone skin often shows a shift toward the more inflammatory varieties.
Biofilms and Why Acne Can Be Stubborn
Inside clogged pores, the bacteria can produce biofilms: thin, sticky layers of protective material that coat bacterial colonies like a shield. Biofilms create a microenvironment with their own gradients of nutrients, oxygen, and acidity, and they make the bacteria dramatically more resistant to antibiotics compared to free-floating bacteria. They also block the immune system from reaching and clearing the infection.
This is a major reason why acne can persist even during treatment. The biofilm acts as a reservoir, sheltering bacteria that can repopulate the pore once treatment stops or loses effectiveness. It also helps explain why acne on the same area of your face can keep coming back in cycles.
Growing Antibiotic Resistance
Decades of antibiotic use for acne have created a significant resistance problem. The proportion of resistant strains rose from about 34.5% in 1991 to 55.5% by 2000 in one large tracking study. More recent data from individual countries paints an even more concerning picture: resistance to common acne antibiotics like erythromycin and clindamycin now exceeds 50% in many regions, reaching as high as 91% in some studies from Spain. In Japan, erythromycin resistance sits around 61%. In China, resistance to clindamycin, erythromycin, and related antibiotics all hover near 55 to 59%.
This is why dermatologists increasingly recommend using antibiotics only in combination with other treatments and for limited durations. Benzoyl peroxide, which kills bacteria through oxidation rather than the mechanisms antibiotics use, does not promote resistance. Clinical trials have shown that combining benzoyl peroxide with a topical antibiotic can reduce bacterial counts by 99.7% within just one week, eliminating both susceptible and resistant strains.
Infections Beyond Acne
While acne is by far the most common condition linked to this bacterium, it can occasionally cause infections in other parts of the body, particularly when medical devices or implants are involved. It has been found infecting prosthetic joints, heart valves, spinal hardware, and other implanted devices. Shoulder replacements are especially vulnerable, likely because the bacterium is so abundant in the skin of the upper chest, back, and shoulders.
The estimated rate of prosthetic joint infection caused by this bacterium is between 0.9% and 1.9%, but the true number may be higher because these infections are notoriously difficult to diagnose. They often develop slowly, producing vague symptoms like persistent low-grade pain rather than the obvious redness and fever associated with other infections. Standard joint fluid samples miss the bacterium roughly 40 to 70% of the time, so a negative initial test doesn’t necessarily rule it out. Surgeons often need multiple tissue samples taken during an operation to confirm the diagnosis.
What the Name Change Means
The reclassification from Propionibacterium acnes to Cutibacterium acnes, proposed around 2016 and widely adopted by 2018, was based on genomic analysis showing that skin-dwelling species in this group had evolved significantly from their relatives in other environments. The new genus name, Cutibacterium, literally references the skin (cutis in Latin). You’ll see both names used interchangeably in medical literature, skincare product marketing, and lab reports. They refer to the same organism.